Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Swiss Medical Weekly|November 3, 2015
Use and role of monoclonal antibodies and other biologics in preventive cardiologyBaris Gencer, Reijo Laaksonen, Aliki Buhayer, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 22, 2025
Viewpoint on the 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of DyslipidaemiasKapka Miteva, Aliki Buhayer, Cédric Follonier, et al.Revue Medicale Suisse|May 27, 2021
[Long-lasting LDL-C lowering: silence at last]Maëlle Achard, Aliki Buhayer, Kevin Dobretz, et al.BMJ Open|May 2, 2023
Clinical practice guidelines for cardiovascular disease: how is depression addressed? Protocol for a systematic reviewDana Blatch Armon, Aliki Buhayer, Kevin Dobretz, et al.Revue Medicale Suisse|May 25, 2022
[A He(art) museum for an existential rebirth after a myocardial infarction]Frédéric Sittarame, Mauricio Estrada-Muñoz, Isabelle Hausmann, et al.Swiss Medical Weekly|July 6, 2023
Translational longevity medicine: a Swiss perspective in an ageing countryMarco M Ruckstuhl, Evelyne Bischof, Dana Blatch, et al.European Heart Journal|August 29, 2025
Depression and cardiovascular disease: mind the gap in the guidelinesDana Blatch Armon, Aliki Buhayer, Kapka Miteva, et al.Clinical Cardiology|November 14, 2018
Design of the randomized, placebo-controlled evolocumab for early reduction of LDL-cholesterol levels in patients with acute coronary syndromes (EVOPACS) trialKonstantinos C Koskinas, Stephan Windecker, Aliki Buhayer, et al.Revue Medicale Suisse|February 5, 2026
[Cardiology : new 2025 guidelines]David Constantin Filip, Renzo Becerra, Simon Édouard Pinaud, et al.Pageof 1